The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 11, 2021
Filed:
Oct. 17, 2018
Applicant:
Precision Biologics, Inc., Rockville, MD (US);
Inventors:
Myron Arlen, Great Neck, NY (US);
Kwong Tsang, Bethesda, MD (US);
Assignee:
PRECISION BIOLOGICS, INC., Rockville, MD (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/30 (2006.01); A61K 47/68 (2017.01); A61K 39/395 (2006.01); G01N 33/574 (2006.01); A61K 49/04 (2006.01); A61K 49/16 (2006.01); A61K 49/22 (2006.01);
U.S. Cl.
CPC ...
C07K 16/303 (2013.01); A61K 39/39558 (2013.01); A61K 47/6859 (2017.08); A61K 49/04 (2013.01); A61K 49/16 (2013.01); A61K 49/221 (2013.01); G01N 33/57438 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/732 (2013.01); C07K 2319/00 (2013.01); G01N 2333/705 (2013.01);
Abstract
The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
Arlen, Myron. (2021). Monoclonal antibody therapy for pancreas cancer (U.S. Patent No. 11001641). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11001641
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile